Neeta Ratanghayra, MPharm
Neeta Ratanghayra is a freelance medical writer specializing in developing content for the pharma, biotech and healthcare industries. She has a Master’s degree in Pharmacy and has worked on a variety of medical writing deliverables for global pharma companies and healthcare organizations. Before delving into medical writing, Neeta worked in the clinical research industry, where she handled multiple clinical research projects intended for various regulatory submissions.
Got a question for Neeta Ratanghayra, MPharm?
Get in touch using the contact form linked here and we’ll get back to you shortly
Published Content
Total: 17
Article
How Can We Unlock New Possibilities in Vaccine Development?
This article covers the challenges associated with conventional vaccine approaches and elaborates on some of the recent innovations which can help design better vaccines.
Article
Nitrosamine Impurities – Understanding Risks, Overcoming Challenges
This article covers the basics of nitrosamines, their related health concerns and key steps taken by health authorities to prevent such product recalls in the future.
Article
Automating Drug Discovery With Machine Learning
The past few decades have witnessed a dramatic growth in the use of novel approaches and technologies in drug discovery. The availability of massive data sets and advanced algorithms has driven more interest and major improvements in the use of artificial intelligence (AI) in the field.
Listicle
Gene Therapy – Insights Into Current Applications and Future Prospects
Download this listicle to learn about key approaches, challenges and advances in gene therapy.
Article
Transforming Drug Discovery Using AI and Automation
The COVID-19 pandemic has unveiled a pressing issue – the need to develop effective drugs rapidly. But developing a new drug is easier said than done. Technologies such as microfluidics, robotics and the use of artificial intelligence, combined with automated data analysis, can expedite the drug development and approval process, helping make therapies available to patients more quickly.
Article
What Led to Reagent Shortages for Coronavirus Testing in the US?
Testing the right person is a crucial aspect in any pandemic. Apart from saving lives, widespread testing can provide important data required to model the course of the outbreak. Reagents are a critical component of testing. Unfortunately, many US labs have struggled to procure the reagents needed to perform large batches of coronavirus diagnostic testing.
Listicle
Key Components of Biopharmaceutical Peptide Mapping
Peptide mapping is an invaluable tool for examining and analyzing biopharmaceuticals, particularly those produced by recombinant means. This list provides an overview of the different uses of peptide mapping, the steps involved, and the key techniques used in peptide detection and analysis.
Advertisement
